Target intelligence / Profile preview

Single-chain type IV collagen (SCCOL-IV)

Target
SCCOL-IV
Molecular classification
Extracellular matrix protein, Collagen
01

Overview

Single-chain type IV collagen (SCCOL-IV), also known as the non-triple helical form of the type IV collagen alpha-1 chain (NTH alpha-1(IV)), is a specialized extracellular matrix protein derived from the COL4A1 gene (Tokunaka et al., 2011). While physiological type IV collagen typically forms a heterotrimeric triple helix essential for basement membrane structure, SCCOL-IV is secreted as a monomeric polypeptide and is predominantly found in the interstitium of malignant tumors (Imamura et al., 2011). It is significantly upregulated during active neovascularization and tumor tissue expansion, where it is thought to facilitate the formation of vascular-like networks (Tokunaka et al., 2011). Because SCCOL-IV is largely absent from normal adult tissues, it serves as a highly specific biomarker for tumor progression and a potential diagnostic tool. Therapeutic interventions targeting SCCOL-IV, such as the monoclonal antibody NK46141, aim to inhibit tumor growth by disrupting pathological vasculogenesis and angiogenesis (Nippon Kayaku, 2015). This specificity for the tumor microenvironment makes SCCOL-IV an attractive target for developing selective anti-cancer therapies with minimal impact on healthy basement membranes.

Other names
Non-triple helical type IV collagen alpha-1 chainNTH alpha-1(IV)SCCOL-IVNon-triple helical form of COL4A1
02

Mechanism of action

Inhibition of tumor vasculogenesis and suppression of tumor tissue expansion through targeted binding by monoclonal antibodies that recognize the non-triple helical conformation of the collagen alpha-1(IV) chain.

03

Biological functions

VasculogenesisAngiogenesisTumor progressionCell signalingExtracellular matrix remodeling
04

Disease associations

CancerTumor growthMetastasisPathological angiogenesis
05

Safety considerations

Potential cross-reactivity with physiological triple-helical type IV collagenImpact on normal basement membrane integrityPotential interference with physiological wound healing or angiogenesisImmunogenicity of therapeutic monoclonal antibodies
06

Interacting drugs

NK46141

1 more in the full profile.

07

Biomarkers

SCCOL-IV expression levelTumor tissue expansion marker

Beyond the preview

Go deeper on Single-chain type IV collagen (SCCOL-IV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single-chain type IV collagen (SCCOL-IV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call